Business
One-shot COVID-19 vaccine may give Johnson & Johnson an edge – New York Post
Less may be more when it comes to rolling out a coronavirus vaccine. Johnson & Johnson’s one-dose vaccine could have an edge over Pfizer and Moderna’s shots– even…
Less may be more when it comes to rolling out a coronavirus vaccine.
Johnson & Johnson’s one-dose vaccine could have an edge over Pfizer and Modernas shots– even though it’s still several weeks away from approval in the US, Wall Street analysts told The Post.
That’s because the single jabs will likely be easier to distribute across the country than its rivals two-dose regimens that are slowly going into Americans arms.
They are not that late, considering the fact that they are shooting for a one-dose…
